中文 | English
Return
Total: 149 , 1/15
Show Home Prev Next End page: GO
Author:(Li-Ping PU)

1.Preliminary study on the mechanism of halofuginone inhibiting the activity of HepG2 cells

Meng-yang CHEN ; Rui-ping HUAI ; Dan-ni YANG ; Li-jie LEI ; Qiu-lin PU ; Li-li XIONG

Acta Pharmaceutica Sinica 2024;59(2):368-373

2.Investigation and analysis of adult skeletal fluorosis caused by drinking tea-type endemic fluorosis in Yushu Tibetan Autonomous Prefecture, Qinghai Province in 2021

Guanglan PU ; Mingjun WANG ; Yanan LI ; Xin ZHOU ; Peizhen YANG ; Ping CHEN ; Qing LU ; Xun CHEN ; Hongting SHEN ; Jing MA ; Jinmei ZHANG ; Cuiling LA ; Qiang ZHANG ; Xianya MENG

Chinese Journal of Endemiology 2024;43(3):207-211

3.Bioequivalence study of gliclazide sustained-release tablets in Chinese healthy subjects

Zhou-Ping DUAN ; Xiao-Wei ZHAO ; Jin-Hua WEN ; Shi-Bo HUANG ; Pu LI ; Duan-Wen CAO

The Chinese Journal of Clinical Pharmacology 2024;40(15):2241-2245

4.Risk prediction models for pancreatic fistula after pancreaticoduodenectomy:A systematic review and a Meta-analysis

Zaichun PU ; Ping JIA ; Juan LIU ; Yushuang SU ; Li WANG ; Qin ZHANG ; Danyang GUO

Journal of Clinical Hepatology 2024;40(11):2266-2276

5.Surgical treatment and prognosis analysis of hilar cholangiocarcinoma

Xiangcheng LI ; Changxian LI ; Hui ZHANG ; Feng CHENG ; Feng ZHANG ; Liyong PU ; Chuanyong ZHANG ; Ke WANG ; Lianbao KONG ; Xiaofeng QIAN ; Donghua LI ; Wenxiong LU ; Ping WANG ; Aihua YAO ; Jianfeng BAI ; Xiaofeng WU ; Ruixiang CHEN ; Xuehao WANG

Chinese Journal of Surgery 2024;62(4):290-301

6.Analysis of epidemiological characteristics of risk factors for cardiovascular diseases and malignant tumors based on the Shanghai community elderly cohort

Ping LI ; Huiru JIANG ; Mengyue YE ; Yayu WANG ; Xiaoyu CHEN ; Ancai YUAN ; Wenjie XU ; Huimin DAI ; Xi CHEN ; Xiaoxiang YAN ; Shengxian TU ; Yuanqi ZHENG ; Wei ZHANG ; Jun PU

Journal of Shanghai Jiaotong University(Medical Science) 2024;44(5):617-625

7.Surgical treatment and prognosis analysis of hilar cholangiocarcinoma

Xiangcheng LI ; Changxian LI ; Hui ZHANG ; Feng CHENG ; Feng ZHANG ; Liyong PU ; Chuanyong ZHANG ; Ke WANG ; Lianbao KONG ; Xiaofeng QIAN ; Donghua LI ; Wenxiong LU ; Ping WANG ; Aihua YAO ; Jianfeng BAI ; Xiaofeng WU ; Ruixiang CHEN ; Xuehao WANG

Chinese Journal of Surgery 2024;62(4):290-301

8.Epidemiological survey of hepatitis B and analysis of hepatitis B vaccine coverage rate among children aged 1-14 years in Lhasa in 2006, 2014 and 2020.

Yong Hong HU ; Zhu Duo Ji DUOJI ; Qian LI ; Li Ping DENG ; Sang Zhuo Ma GONGSANG ; Bai SUO ; Zhen PU ; Tian TIAN ; Ren De Ji DEJI ; Zhen QIONG

Chinese Journal of Preventive Medicine 2023;57(3):406-410

9.Combination immunotherapy of glioblastoma with dendritic cell cancer vaccines,anti-PD-1 and poly I:C

Ping ZHU ; Shi-You LI ; Jin DING ; Zhou FEI ; Sheng-Nan SUN ; Zhao-Hui ZHENG ; Ding WEI ; Jun JIANG ; Jin-Lin MIAO ; San-Zhong LI ; Xing LUO ; Kui ZHANG ; Bin WANG ; Kun ZHANG ; Su PU ; Qian-Ting WANG ; Xin-Yue ZHANG ; Gao-Liu WEN ; Jun O.LIU ; Thomas-John AUGUST ; Huijie BIAN ; Zhi-Nan CHEN ; You-Wen HE

Journal of Pharmaceutical Analysis 2023;13(6):616-624

10.Analysis of external quality control assessment results of fluorine and arsenic in Qinghai Province in 2021

Guanglan PU ; Cuiling LA ; Qiang ZHANG ; Ping CHEN ; Qing LU ; Peizhen YANG ; Xin ZHOU ; Yanan LI ; Ping YANG ; Mingjun WANG ; Lansheng HU ; Xianya MENG

Chinese Journal of Endemiology 2023;42(1):65-68

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 149 , 1/15 Show Home Prev Next End page: GO